Retagliptin Phosphate

SKU: orb1309167

Description

Retagliptin Phosphate (SP 2086) is a small molecule DPP-4 inhibitor used in research for type 2 diabetes. It is applied in both in vitro enzymatic assays and in vivo animal studies to investigate mechanisms of glycemic control and incretin hormone potentiation.

Research Area

Protein Biochemistry

Key Properties

• CAS Number: 1256756-88-3
• MW: 562.36
• Purity: 98.97%
• Formula: C₁₉H₂₁F₆N₄O₇P
• SMILES: P(=O)(O)(O)O.C(OC)(=O)C1=C2N(C(C(F)(F)F)=N1)CCN(C(C[C@@H](CC3=C(F)C=C(F)C(F)=C3)N)=O)C2
• Target: DPP-4,Proteasome
• Solubility: DMSO:≥ 150 mg/mL (266.73 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.56 mM)

Storage & Handling

• Storage: Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

GLP-1, Inhibitor, inhibit, DPP, DPP-4, DPP4, Dipeptidyl Peptidase, Retagliptin, Retagliptin Phosphate, T2DM, SP2086, SP-2086, SP 2086

Compound Identifiers

PubChem CID

49820554